Arcutis Biotherapeutics (ARQT) Retained Earnings (2020 - 2025)
Historic Retained Earnings for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Q3 2025 value amounting to -$1.2 billion.
- Arcutis Biotherapeutics' Retained Earnings fell 398.67% to -$1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 billion, marking a year-over-year decrease of 398.67%. This contributed to the annual value of -$1.1 billion for FY2024, which is 1426.2% down from last year.
- According to the latest figures from Q3 2025, Arcutis Biotherapeutics' Retained Earnings is -$1.2 billion, which was down 398.67% from -$1.2 billion recorded in Q2 2025.
- In the past 5 years, Arcutis Biotherapeutics' Retained Earnings registered a high of -$238.0 million during Q1 2021, and its lowest value of -$1.2 billion during Q2 2025.
- In the last 5 years, Arcutis Biotherapeutics' Retained Earnings had a median value of -$870.9 million in 2023 and averaged -$789.3 million.
- Per our database at Business Quant, Arcutis Biotherapeutics' Retained Earnings crashed by 15238.6% in 2021 and then plummeted by 398.67% in 2025.
- Over the past 5 years, Arcutis Biotherapeutics' Retained Earnings (Quarter) stood at -$408.3 million in 2021, then crashed by 76.29% to -$719.8 million in 2022, then crashed by 36.41% to -$981.9 million in 2023, then dropped by 14.26% to -$1.1 billion in 2024, then dropped by 2.99% to -$1.2 billion in 2025.
- Its Retained Earnings was -$1.2 billion in Q3 2025, compared to -$1.2 billion in Q2 2025 and -$1.1 billion in Q1 2025.